Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

Author： Garçon Nathalie   Morel Sandra   Didierlaurent Arnaud   Descamps Dominique   Wettendorff Martine   >  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.4, 2011-08, pp. : 217-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)†

By McKeage Kate  

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 265-269

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™]: Profile Report

By Keam Susan J.  

BioDrugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 205-208

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine

By Dooley M.   Goa K.L.  

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 61-69

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine: A Viewpoint by R. Baltussen

By Baltussen R.  

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 70-71

Adis International

Access to resources Recommend Favorite

Prospects for the Development of New Vaccine Adjuvants

By Cox J.   Coulter A.  

BioDrugs, Vol. 12, Iss. 6, 1999-12 ,pp. : 439-453

Adis International

Access to resources Recommend Favorite